Table 2.
(A) 3-year survival estimates | |||||
---|---|---|---|---|---|
pN0/PNI+ vs. pN0/PNI− (95% CI) | |||||
n | Overall Survival | Disease Specific Survival | Disease Free Interval | Local Regional Control | |
pN0/PNI+ | 20 | 70% (45–85) | 78% (52–91) | 64% (38–81) | 65% (40–82) |
pN0/PNI− | 68 | 83% (72–90) | 90% (80–95) | 79% (66–87) | 84% (73–91) |
pN0/PNI+ with Radiation vs. pN0/PNI+ without Radiation (95% CI) | |||||
n | Overall Survival | Disease Specific Survival | Disease Free Interval | Local Regional Control | |
PNI+ No Radiation | 6 | 83% (27–97) | 83% (27–97) | 33% (5–68) | 50% (11–80) |
PNI+ Plus Radiation | 14 | 64% (34–83) | 76% (43–92) | 77% (45–92) | 71% (41–88) |
(B) 5-year survival estimates | |||||
---|---|---|---|---|---|
pN0/PNI+ vs. pN0/PNI− (95% CI) | |||||
n | Overall Survival | Disease Specific Survival | Disease Free Interval | Local Regional Control | |
pN0/PNI+ | 20 | 48% (22–70) | 62% (33–82) | 50% (25–71) | 52% (27–72) |
PN0/PNI− | 68 | 74% (61–83) | 86% (75–92) | 77% (64–86) | 82% (71–89) |
pN0/PNI+ with Radiation vs. pN0/PNI+ without Radiation (95% CI) | |||||
n | Overall Survival | Disease Specific Survival | Disease Free Interval | Local Regional Control | |
PNI+ No Radiation | 6 | 42% (1–84) | 42% (1–84) | 33% (5–68) | 50% (11–80) |
PNI+ Plus Radiation | 14 | 46% (18–70) | 65% (31–86) | 68% (34–87) | 63% (33–83) |
pN0 = pathologically N-0; PNI = Perineural invasion